Literature DB >> 8433213

Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.

J Bártek1, J Bártková, J Lukás, Z Stasková, B Vojtĕsek, D P Lane.   

Abstract

Alterations of the p53 tumour suppressor gene are considered critical events in multistage carcinogenesis of a wide range of human cancers. In an attempt to elucidate the role of various p53 mutations in tumorigenesis and to investigate their relationship to the p53 protein accumulation and subcellular localization, we have raised a new series of 21 mouse monoclonal antibodies (MAbs) to human recombinant p53. The new MAbs (designated the Bp53 series) appear to recognize mainly denaturation-resistant epitopes in immunoblotting and the majority of them are suitable for immunostaining of p53 in cultured cells and frozen sections. Furthermore, at least three MAbs (Bp53-11, Bp53-12, and Bp53-28) proved to be reliable reagents for immunohistochemistry on paraffin-embedded specimens. The immunohistochemical analysis of paraffin sections from 118 human tumours of various histogeneses with Bp53-11 and Bp53-12 showed nuclear accumulation of the p53 protein in variable proportion of tumour cells in 76 cases (64 per cent). The influence of three parameters of tissue processing (type of fixative, period of fixation, and duration of autolysis) on p53 protein detection was also investigated. The results of this study provide the necessary basis for wider application of these novel MAbs as tools in both routine histopathology and functional analyses of the p53 oncoprotein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433213     DOI: 10.1002/path.1711690106

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.

Authors:  Jirina Bartkova; Christina E Hoei-Hansen; Katerina Krizova; Petra Hamerlik; Niels E Skakkebæk; Ewa Rajpert-De Meyts; Jiri Bartek
Journal:  Mol Oncol       Date:  2014-07-09       Impact factor: 6.603

2.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

3.  Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection.

Authors:  N L Jones; P T Shannon; E Cutz; H Yeger; P M Sherman
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis.

Authors:  M Schmid; K Janssen; B Dockhorn-Dworniczak; D Metze; B W Zelger; T A Luger; K W Schmid
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

5.  Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.

Authors:  A Wee; M Teh; G C Raju
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

6.  Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.

Authors:  J F Zhang; C Hu; Y Geng; J Selm; S B Klein; A Orazi; M W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.

Authors:  Luca Lavra; Cinzia Rinaldo; Alessandra Ulivieri; Emidio Luciani; Paolo Fidanza; Laura Giacomelli; Carlo Bellotti; Alberto Ricci; Maria Trovato; Silvia Soddu; Armando Bartolazzi; Salvatore Sciacchitano
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

8.  Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

Authors:  C J Fisher; C E Gillett; B Vojtĕsek; D M Barnes; R R Millis
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

9.  Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

Authors:  B Schlichtholz; J Trédaniel; R Lubin; G Zalcman; A Hirsch; T Soussi
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

10.  p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry.

Authors:  G M Horne; J J Anderson; D G Tiniakos; G G McIntosh; M D Thomas; B Angus; J A Henry; T W Lennard; C H Horne
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.